FR2297034B1 - - Google Patents

Info

Publication number
FR2297034B1
FR2297034B1 FR7600251A FR7600251A FR2297034B1 FR 2297034 B1 FR2297034 B1 FR 2297034B1 FR 7600251 A FR7600251 A FR 7600251A FR 7600251 A FR7600251 A FR 7600251A FR 2297034 B1 FR2297034 B1 FR 2297034B1
Authority
FR
France
Prior art keywords
carrier
disclosed
radioisotope
scanning agents
scanning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7600251A
Other languages
English (en)
Other versions
FR2297034A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atomic Energy of Canada Ltd AECL
Original Assignee
Atomic Energy of Canada Ltd AECL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atomic Energy of Canada Ltd AECL filed Critical Atomic Energy of Canada Ltd AECL
Publication of FR2297034A1 publication Critical patent/FR2297034A1/fr
Application granted granted Critical
Publication of FR2297034B1 publication Critical patent/FR2297034B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7600251A 1975-01-07 1976-01-07 Composition pour la localisation d'isotopes radioactifs en medecine Granted FR2297034A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/539,134 US3992513A (en) 1975-01-07 1975-01-07 Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs

Publications (2)

Publication Number Publication Date
FR2297034A1 FR2297034A1 (fr) 1976-08-06
FR2297034B1 true FR2297034B1 (fr) 1978-11-03

Family

ID=24149936

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7600251A Granted FR2297034A1 (fr) 1975-01-07 1976-01-07 Composition pour la localisation d'isotopes radioactifs en medecine

Country Status (6)

Country Link
US (2) US3992513A (fr)
CA (1) CA1100871A (fr)
DE (1) DE2600311A1 (fr)
FR (1) FR2297034A1 (fr)
GB (1) GB1503461A (fr)
NL (1) NL7600104A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070493A (en) * 1977-03-16 1978-01-24 Merck & Co., Inc. Diagnostic kit
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4387087A (en) * 1980-04-18 1983-06-07 Research Corporation Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging
US4489054A (en) * 1980-04-18 1984-12-18 Research Corporation Cationic lipophilic complexes of 99m Tc and their use for myocardial and hepatobiliary imaging
US4406876A (en) * 1980-10-14 1983-09-27 Research Foundation Of The State Univ. Of New York Sulfur free small-particle production of technetium sulfur colloid
AU561747B2 (en) * 1982-03-25 1987-05-14 Mallinckrodt, Inc. Method and apparatus for the diagnosis of respiratory diseases and allergies
US5441745A (en) * 1982-03-30 1995-08-15 Vestar, Inc. Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
US5435989A (en) 1982-03-30 1995-07-25 Vestar, Inc. Method of targeting a specific location in a body
GB8310038D0 (en) * 1983-04-13 1983-05-18 Amersham Int Plc Technetium-99 labelled tin colloid
US5019369A (en) * 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
CA1267840A (fr) * 1984-11-23 1990-04-17 Cary Arnet Presant Methode de ciblage des tumeurs chez les humains
US4877619A (en) * 1986-08-25 1989-10-31 Vestar, Inc. Liposomal vesicles for intraperitoneal administration of therapeutic agents
EP0386146B1 (fr) * 1987-11-04 1993-04-28 Vestar, Inc. Composition et procede d'utilisation de composes encapsules dans des liposomes pour une therapie de tumeurs par capture de neutrons
US5328678A (en) * 1987-11-04 1994-07-12 Vestar, Inc. Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas
US5874059A (en) * 1992-04-02 1999-02-23 Fundacao E.J. Zerbini Microemulsions labelled with radioactivity used as means for targeting neoplastic cells
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US5607653A (en) * 1995-03-17 1997-03-04 Mainstream Engineering Corporation Process and apparatus for oxidizing and neutralizing caustic waste to liquid fertilizer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663685A (en) * 1968-04-01 1972-05-16 Minnesota Mining & Mfg Biodegradable radioactive particles
US3597455A (en) * 1969-05-29 1971-08-03 Squibb & Sons Inc Process for manufacture of sterile lecithin
BE786566A (fr) * 1971-07-20 1973-01-22 Squibb & Sons Inc Agregats a base de tc-99m et d'albumine
US3863004A (en) * 1972-03-20 1975-01-28 Mallinckrodt Chemical Works Denatured macroprotein with divalent tin for tagging with technetium-99m and method of preparation

Also Published As

Publication number Publication date
US3992513A (en) 1976-11-16
NL7600104A (nl) 1976-07-09
GB1503461A (en) 1978-03-08
US4086330A (en) 1978-04-25
DE2600311A1 (de) 1976-07-08
FR2297034A1 (fr) 1976-08-06
CA1100871A (fr) 1981-05-12

Similar Documents

Publication Publication Date Title
FR2297034B1 (fr)
ZA805813B (en) Composition and method for cancer detection in humans
AU6198086A (en) Agents for use in tumour diagnosis, imaging, localization or treatment
DK507183A (da) Bifunktionelt chelateringsmiddel
ZA879076B (en) Detection of necrotic malignant tissue and associated therapy
EP0188256A3 (en) Metal radionuclide labeled proteins for diagnosis and therapy
EP0248887A4 (fr) Recepteur antigenique de cellules t exempt de cellules et ses utilisations cliniques.
JPS5223083A (en) New 1*2*3*44tetrahydraquinoline derivatives preparation method thereof and medical composite containing these
DE3364983D1 (en) Technetium-99m-tetraphosphonates for the scintigraphic visualisation of the r.e.s. organs and lymph vessels, and preparation process
US3997784A (en) Automatic apparatus for dispensing radiodiagnostic agents and method therefor
JPS5244243A (en) Composition for making technetium radiation diagnostic agent
NZ215513A (en) Boronic acid adducts of technetium-99m dioxime complexes and use as imaging agents
SE8000074L (sv) Kontrastmedel
NL176748B (nl) Werkwijze voor het bereiden van een verbinding van tweewaardig tin bevattend preparaat, geschikt voor de bereiding van op technetium-99m gebaseerde, radiografische schermbeeldvormende middelen, alsmede kits, bevattende een dergelijk preparaat.
SE8002844L (sv) Framstellning och anvendning av en ?72195m au-haltig vetska
JPS5244244A (en) Composition for making technetium radiation diagnostic agent
EP0096871A3 (fr) Composition pour faire une image de cellules sanguines
ATE203417T1 (de) Radioaktiv markierte somatostatin
ZA887113B (en) Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes
JPS5261230A (en) Technetiumm99m labelling kidney diagnostic agent and method of making same
SE7609977L (sv) Forfaringssett for framstellning av radioaktivt merkt orgotein
JPS54101416A (en) Radioactive technetium labelled diagnostic agent
GB1550914A (en) Malignant tumour diagnostic method kit and materials
EP0273754A3 (fr) Méthode pour augmenter la biodistribution d'anticorps pour la localisation dans des lésions
DE3875290D1 (de) Verwendung eines vehikels mit hoher affinitaet zu tumoren.

Legal Events

Date Code Title Description
ST Notification of lapse